Abstract
Objective: Previous reports in ovarian, breast, and colorectal cancer using the Surveillance Epidemiology and End Results database have demonstrated negative outcomes associated with delays in delivery of adjuvant therapy. Using prospectively collected data, we sought to determine whether the interval from surgery to initiation of chemotherapy (SIT) affects survival in advanced ovarian carcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
